What is HC Wainwright’s Forecast for Liquidia Q3 Earnings?

Liquidia Co. (NASDAQ:LQDA) – Research analysts at HC Wainwright reduced their Q3 2025 earnings estimates for Liquidia in a research note issued to investors on Wednesday, May 28th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($0.33) per share for the quarter, down from their previous forecast of ($0.30). HC Wainwright currently has a “Buy” rating and a $35.00 target price on the stock. The consensus estimate for Liquidia’s current full-year earnings is ($1.51) per share. HC Wainwright also issued estimates for Liquidia’s Q4 2025 earnings at ($0.26) EPS, FY2025 earnings at ($1.46) EPS, FY2026 earnings at ($0.53) EPS, FY2027 earnings at $0.07 EPS, FY2028 earnings at $0.48 EPS and FY2029 earnings at $1.44 EPS.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.03). Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%. The business had revenue of $3.12 million for the quarter, compared to analyst estimates of $3.23 million.

Other research analysts have also recently issued research reports about the stock. Scotiabank increased their target price on shares of Liquidia from $36.00 to $37.00 and gave the stock a “sector outperform” rating in a report on Wednesday. Oppenheimer set a $13.00 target price on shares of Liquidia and gave the stock an “underperform” rating in a report on Monday, May 19th. Wall Street Zen upgraded shares of Liquidia from a “sell” rating to a “hold” rating in a report on Thursday, May 22nd. BTIG Research restated a “buy” rating on shares of Liquidia in a report on Tuesday. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $25.00 price target on shares of Liquidia in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, six have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $26.67.

Liquidia Trading Up 0.2%

Shares of LQDA opened at $15.03 on Friday. Liquidia has a 12 month low of $8.26 and a 12 month high of $19.41. The firm has a fifty day simple moving average of $14.71 and a 200 day simple moving average of $13.74. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -9.22 and a beta of 0.24.

Institutional Trading of Liquidia

Hedge funds and other institutional investors have recently bought and sold shares of the business. DMC Group LLC boosted its holdings in shares of Liquidia by 17.4% in the 4th quarter. DMC Group LLC now owns 16,302 shares of the company’s stock worth $192,000 after buying an additional 2,419 shares during the last quarter. Catalina Capital Group LLC lifted its holdings in shares of Liquidia by 6.5% in the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company’s stock worth $215,000 after buying an additional 1,125 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Liquidia by 3.5% in the fourth quarter. Rhumbline Advisers now owns 80,652 shares of the company’s stock worth $948,000 after buying an additional 2,741 shares in the last quarter. Sigma Planning Corp lifted its holdings in shares of Liquidia by 3.4% in the fourth quarter. Sigma Planning Corp now owns 65,210 shares of the company’s stock worth $767,000 after buying an additional 2,115 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Liquidia by 3.3% in the fourth quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company’s stock worth $2,218,000 after buying an additional 6,034 shares in the last quarter. Institutional investors own 64.54% of the company’s stock.

Insider Activity

In other news, CEO Roger Jeffs sold 14,130 shares of the firm’s stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the sale, the chief executive officer now directly owns 1,006,420 shares in the company, valued at approximately $13,657,119.40. This trade represents a 1.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jason Adair sold 1,856 shares of Liquidia stock in a transaction on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $25,185.92. Following the completion of the sale, the insider now owns 184,304 shares of the company’s stock, valued at $2,501,005.28. This represents a 1.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,138 shares of company stock valued at $450,233 over the last ninety days. 26.50% of the stock is currently owned by company insiders.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).